DE68910386D1 - Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken. - Google Patents

Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken.

Info

Publication number
DE68910386D1
DE68910386D1 DE89305478T DE68910386T DE68910386D1 DE 68910386 D1 DE68910386 D1 DE 68910386D1 DE 89305478 T DE89305478 T DE 89305478T DE 68910386 T DE68910386 T DE 68910386T DE 68910386 D1 DE68910386 D1 DE 68910386D1
Authority
DE
Germany
Prior art keywords
triglycerides
cholesterol
mammals
beta
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89305478T
Other languages
English (en)
Other versions
DE68910386T2 (de
Inventor
Rolf Kristian Berge
Jon Bremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norsk Hydro ASA
Original Assignee
Norsk Hydro ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro ASA filed Critical Norsk Hydro ASA
Publication of DE68910386D1 publication Critical patent/DE68910386D1/de
Application granted granted Critical
Publication of DE68910386T2 publication Critical patent/DE68910386T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
DE68910386T 1988-06-02 1989-05-31 Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken. Expired - Lifetime DE68910386T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813012A GB8813012D0 (en) 1988-06-02 1988-06-02 Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Publications (2)

Publication Number Publication Date
DE68910386D1 true DE68910386D1 (de) 1993-12-09
DE68910386T2 DE68910386T2 (de) 1994-06-09

Family

ID=10637920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68910386T Expired - Lifetime DE68910386T2 (de) 1988-06-02 1989-05-31 Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken.

Country Status (8)

Country Link
US (1) US5093365A (de)
EP (1) EP0345038B1 (de)
AT (1) ATE96664T1 (de)
CA (1) CA1329550C (de)
DE (1) DE68910386T2 (de)
DK (1) DK267689A (de)
ES (1) ES2059749T3 (de)
GB (1) GB8813012D0 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376688B1 (en) 1994-10-13 2002-04-23 Peptide Technology Limited Modified polyunsaturated fatty acids
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
US20020074691A1 (en) * 1999-09-14 2002-06-20 Robert M Mortellite High speed method of making plastic film and nonwoven laminates
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
AR035533A1 (es) * 2001-01-26 2004-06-02 Schering Corp Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
US20020151536A1 (en) * 2001-01-26 2002-10-17 Schering Corporation Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
CA2434033A1 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
CA2434488A1 (en) * 2001-01-26 2002-08-01 Harry R. Davis Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
SK9502003A3 (en) * 2001-01-26 2003-12-02 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
EP1385548B1 (de) * 2001-01-26 2007-05-23 Schering Corporation Kombinationen eines hemmers der sterolabsorption und eines kardiovaskulären wirkstoffes zur behandlung von kardiovaskulären indikationen
AR038956A1 (es) * 2001-05-25 2005-02-02 Schering Corp Uso de un compuesto que regula la produccion o niveles de peptidos beta amiloides para la manufactura de un medicamento para tratar la enfermedad de alzheimer y/o para regular dichos niveles de peptidos amiloides beta en un sujeto
FR2828487B1 (fr) * 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
JP2005504091A (ja) * 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DK1427409T3 (da) * 2001-09-21 2009-01-12 Schering Corp Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
EP1515978A1 (de) 2002-06-20 2005-03-23 IC Vec Limited Schwefelhaltige phospholipidderivate
US20040067267A1 (en) * 2002-10-08 2004-04-08 Murthy Pothapragada Suryanarayana Process for preparation of cholesterol lowering compositions from garlic
MXPA05004811A (es) * 2002-11-06 2005-07-22 Schering Corp Inhibidores de absorcion de colesterol para el tratamiento de trastornos autoinmunes.
MXPA05009503A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7208486B2 (en) * 2003-03-07 2007-04-24 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CA2544309A1 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
JP2007522118A (ja) * 2004-01-30 2007-08-09 ペプリン バイオリピッズ ピーティーワイ エルティーディー 治療用分子および担体分子
KR20070054637A (ko) * 2004-07-19 2007-05-29 티아 메디카 에이에스 식물유 및/또는 어유 및 비-산화성 지방산 구성요소를포함하는 조성물
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US10154979B2 (en) 2013-03-11 2018-12-18 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (de) * 1972-02-23 1973-09-27 Kolmar Laboratories Neue alkylthioaether
NL7405744A (en) * 1974-04-29 1975-10-31 Dow Chemical Co Butylphenyl-thioalkane carboxylic acids - as hypocholesterolaemics and antilipaemics from corresp. thiophenols and haloalkane carboxylic acids
DE2515146A1 (de) * 1975-04-08 1976-10-21 Bayer Ag Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2856683A1 (de) * 1978-12-29 1980-07-17 Nattermann A & Cie Entzuendungshemmende und antiatherosklerotisch wirkende arzneimittel
CH661207A5 (en) * 1980-06-30 1987-07-15 Hoerrmann Wilhelm Pharmaceutical composition containing long-chain aldehydes or carboxylic acids

Also Published As

Publication number Publication date
EP0345038A3 (de) 1991-06-12
EP0345038B1 (de) 1993-11-03
US5093365A (en) 1992-03-03
ATE96664T1 (de) 1993-11-15
GB8813012D0 (en) 1988-07-06
DK267689A (da) 1989-12-03
EP0345038A2 (de) 1989-12-06
ES2059749T3 (es) 1994-11-16
CA1329550C (en) 1994-05-17
DK267689D0 (da) 1989-06-01
DE68910386T2 (de) 1994-06-09

Similar Documents

Publication Publication Date Title
DE68910386D1 (de) Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken.
ATE74361T1 (de) Cycloalkylaminomethylenbisphosphonsaeuren und medikamente, die sie enthalten.
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
ES2031913T3 (es) Un procedimiento para preparar un derivado de quinazolinona.
EP0257086A4 (de) Hautpenetration verbessernde Zusammensetzungen.
GR3002672T3 (en) Compositions and methods for the treatment of bleeding disorders
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
ATE224188T1 (de) Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung
DE3672094D1 (de) Verwendung von sophoroselipid-lacton zur bekaempfung von kopfschuppen und koerpergeruch.
ATE66609T1 (de) Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
IE882529L (en) Platinum Coordination Compound
DE3775666D1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
DK0488928T3 (da) Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
GR852867B (de)
FR2521140B1 (de)
DE3665320D1 (en) Stabilization of peroxidase activity in solution
FI873574A (fi) Platinaderivat.
ATE68469T1 (de) Verfahren zur herstellung von alkylpyruvaten.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
AR248137A1 (es) Procedimiento para la preparacion de 4-alquil-1, 4-dihidropiridinas con actividad paf-antagonista.
KR850007069A (ko) N-아실화 1-알킬아미노-1-데옥시-케토오스 유도체의 제조방법
ATE53847T1 (de) Stroma-freie haemoglobinloesung, verfahren zu ihrer herstellung und ihre verwendung.
FR2591591B1 (fr) Alkylcarboxamides de pyridylalkylamines, leurs preparations et leur utilisation en tant que medicaments

Legal Events

Date Code Title Description
8364 No opposition during term of opposition